Frontiers in Cellular and Infection Microbiology · 2023 · 27 citations · 32 references
Life SciencesInfectious DiseasesMicrobiologyBacteriologyMedical MicrobiologyMicrobial PathogenesisLactic Acid BacteriaMicrobial Physiology In FermentationAntimicrobial MetabolitesBiofilm DevelopmentCandida Albicans InfectionCandida BiofilmsRecurrent Vulvovaginal Candidiasis ManagementRecurrent Vulvovaginal InfectionsVaginal CandidiasisVulvovaginal Candidiasis Treatment
Introduction Antifungal agents are not always efficient in resolving vulvovaginal candidiasis (VVC), a common genital infection caused by the overgrowth of Candida spp., including Candida albicans , or in preventing recurrent infections. Although lactobacilli (which are dominant microorganisms constituting healthy human vaginal microbiota) are important barriers against VVC, the Lactobacillus metabolite concentration needed to suppress VVC is unknown. Methods We quantitatively evaluated Lactobacillus metabolite concentrations to determine their effect on Candida spp., including 27 vaginal strains of Lactobacillus crispatus, L. jensenii, L. gasseri, Lacticaseibacillus rhamnosus , and Limosilactobacillus vaginalis , with inhibitory abilities against biofilms of C. albicans clinical isolates. Results Lactobacillus culture supernatants suppressed viable fungi by approximately 24%-92% relative to preformed C. albicans biofilms; however, their suppression differed among strains and not species. A moderate negative correlation was found between Lactobacillus lactate production and biofilm formation, but no correlation was observed between hydrogen peroxide production and biofilm formation. Both lactate and hydrogen peroxide were required to suppress C. albicans planktonic cell growth. Lactobacillus strains that significantly inhibited biofilm formation in culture supernatant also inhibited C. albicans adhesion to epithelial cells in an actual live bacterial adhesion competition test. Discussion Healthy human microflora and their metabolites may play important roles in the development of new antifungal agent against C. albicans -induced VVC.
32
Vaginal microbiome of reproductive-age women
Jacques Ravel, Pawel Gajer, Zaid Abdo et al. · Proceedings of the National Academy of Sciences · 2010 · 4.2K citations
Life Sciences, Biology, Microbiology +14
Candidalysin is a fungal peptide toxin critical for mucosal infection
David L. Moyes, Duncan Wilson, Jonathan P. Richardson et al. · Nature · 2016 · 899 citations · Full text
Function of <i>Candida albicans</i> Adhesin Hwp1 in Biofilm Formation
Clarissa J. Nobile, Jeniel E. Nett, David R. Andes et al. · Eukaryotic Cell · 2006 · 385 citations · Full text
Steven S. Witkin, Helena Mendes‐Soares, Iara M. Linhares et al. · mBio · 2013 · 382 citations · Full text